⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VTGN News
Vistagen Therapeutics, Inc. Common Stock
Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update
businesswire.com
VTGN
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
businesswire.com
VTGN
Vistagen to Participate in Stifel Healthcare Conference 2025
businesswire.com
VTGN
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
businesswire.com
VTGN
Vistagen Appoints Paul Edick to its Board of Directors
businesswire.com
VTGN
VTGN
Vistagen to Present at The Menopause Society 2025 Annual Meeting
businesswire.com
VTGN
VTGN
Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
businesswire.com
VTGN
VTGN